Search
for
Sort by
Research 30 of 230
- The PDE4 inhibitor, apremilast, suppresses experimentally induced alopecia areata in human skin in vivo
- A randomized placebo-controlled single-center pilot study of the safety and efficacy of apremilast in subjects with moderate-to-severe alopecia areata
- Apremilast treatment of atopic dermatitis and other chronic eczematous dermatoses
- Lack of efficacy of apremilast in 9 patients with severe alopecia areata
- Long-term treatment with apremilast in hidradenitis suppurativa: A 2-year follow-up of initial responders
- Apremilast for extensive and treatment-resistant alopecia areata: a retrospective analysis of five patients
- Efficacy of the phosphodiesterase-4 inhibitor, apremilast, in a patient with severe alopecia areata
- Apremilast is efficacious in refractory alopecia areata
- Apremilast and tofacitinib exert differential effects in the humanized mouse model of alopecia areata
- The relative efficacy of monotherapy with Janus kinase inhibitors, dupilumab and apremilast in adults with alopecia areata: Network meta‐analyses of clinical trials
- Non-FDA-Approved Uses of Apremilast in Dermatology: A Review of Current Available literature
- Apremilast for Lichen Planopilaris and Frontal Fibrosing Alopecia: A Case Series
- Efficacy of Oral Apremilast in The Treatment of Alopecia Areata, at The Tertiary Care Hospital, Karachi
- Comparing the efficacy of oral apremilast, intralesional corticosteroids, and their combination in patients with patchy alopecia areata: a randomized clinical controlled trial
- Alopecia Areata: an Update on Etiopathogenesis, Diagnosis, and Management
- Primary cicatricial alopecia
- Alopecia areata: Animal models illuminate autoimmune pathogenesis and novel immunotherapeutic strategies
- The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm
- Cytokine Targeted Therapeutics for Alopecia Areata: Lessons from Atopic Dermatitis and Other Inflammatory Skin Diseases
- Comparative efficacy of oral Janus kinase inhibitors and biologics in adult alopecia areata: A systematic review and Bayesian network meta‐analysis
- Systematic review of newer agents for the management of alopecia areata in adults: Janus kinase inhibitors, biologics and phosphodiesterase‐4 inhibitors
- Phosphodiesterase inhibitors and prostaglandin analogues in dermatology: A comprehensive review
- Novel therapies for alopecia areata: The era of rational drug development
- A narrative review of therapies for scalp dermatomyositis
- Frontal fibrosing alopecia: a disease fascinating for the researcher, disappointing for the clinician and distressing for the patient
- Drugs targeting epithelial–mesenchymal transition molecules for treatment of lichen planopilaris
- The use of phosphodiesterase inhibitors for the treatment of alopecia
- Cytokine-targeted treatment in alopecia areata - new possibilities?
- Comment on ‘Androgenetic alopecia is associated with increased scalp hardness’: role of phosphodiesterase inhibitors?
- Sequential small-molecule therapy for lymphocytic cicatricial alopecia: A multicenter prospective cohort pilot study